Program

Symposium on Molecular and Physiological Aspects of Diabetes Mellitus

November 13, 2015

9:00 - 9:10 Welcome Note

Juleen Zierath

9:10 - 9:20 The 4D Type 2 diabetes project: Standardized care process, a platform for

excellent care and research

Eva Toft, Ersta Hospital

9:20 - 9:55 The Kidney in Diabetes

Sally Marshall, Institute of Cellular Medicine, Newcastle University, UK

9:55 - 10:30 The diabetes epidemic: fact and fiction

Sarah Wild, Centre for Population Health Sciences, University of Edinburgh, UK

10:30 - 11:00 COFFEE BREAK

11:00 - 11:35 Genes and Metabolism: What lessons have we learned so far?

Inês Barroso, Wellcome Trust Sanger Institute, Hinxton, UK

11:35-12:10 Insulin resistance in cardiovascular disease development

Markku Laakso, Dept. of Medicine, University of Kuopio, Finland

12:10-13:10 LUNCH

13:10- 13:45 Metabolic dysregulation and insulin action: human phenotypic considerations

William T. Cefalu, Pennington Biomedical Research Center, New Orleans, USA

13:45-14:20 Obesity-related Insulin Resistance: A Systems Approach

Daniel P. Kelly, Sanford Burnham Prebys Medical Discovery Institute at Lake

Nona, Orlando, USA

14:20-14:50 COFFEE BREAK

14:50-15:25 Taking care of the gut microbiota to control diabetes and related metabolic

diseases

Nathalie Delzenne, Metabolism and Nutrition Research Group, Catholic

University of Louvain, Louvain Drug Research Institute (LDRI), Belgium

15:25-16:00 Aging of the autophagic system: Metabolic consequences

Ana Maria Cuervo, Albert Einstein College of Medicine, New York, USA

CLOSING REMARKS